Lyell Immunopharma, Inc. - COM (LYEL)

Q2 2023 13F Holders as of 6/30/2023

Type / Class
Equity / COM
Number of holders
97
Total Shares
122M
Shares change
+4.46M
Total reported value, excl. options
$389M
Value change
+$15.2M
Put/Call ratio
11.33
Number of buys
46
Number of sells
-49
Price
$3.18
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.